One year of Lamivudine therapy for portuguese patients with chronic hepatitis B.

Jorge Areias,F. Calinas,A. Porto,A. Carvalho,D. M. S. Freitas,Guilherme Macedo,R.Noronha,José Cotter,A. Meliço-Silvestre,R. Peixe,J. Pratas,D Barrote,Renan Kleber Costa Teixeira,F. Augusto,I Carrilho,F Campante,José Velosa,Laura Carvalho,Maria Antónia Duarte,Horácio Guerreiro,C. Pires,A Silva,I Cotrim,F. Guedes,Tomé L,M. Marcelino,Cristina Gonçalves,Etelvina Ferreira,L. Matos,P. Peixe,Joana Esteves,T. Valente,Cláudia Maria Oliveira Simões,Carla Marinho,Luís Jasmins,M. J. Vieira,Rui Tato Marinho,Paula Mena Matos,J. Estevens,J. Carrasquinho,G. Salcedo,P. Parada,C. Teixeira

One year of Lamivudine therapy for portuguese patients with chronic hepatitis B.

2003

Objective: To assess the efficacy of lamivudine treatment on hepatitis B e antigen (HBeAg) and/or hepatitis B surface antigen (HBsAg) seroconversion, on other virological and serological markers of response including hepatitis B virus (HBV) DNA and serum aminotransferases, and the safety of lamivudine treatment in hepatitis B patients.

Keywords:

Hepatitis B
HBsAg
Seroconversion
HBeAg
Serology
Hepatitis B virus
Medicine
Lamivudine
Virology
Antigen
Pharmacotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations